This publication is presented to you through Paradigm Publishing Services
Rutgers University Press
Chapter
Licensed
Unlicensed
Requires Authentication
INTRODUCTION
-
Conrad Keating
You are currently not able to access this content.
You are currently not able to access this content.
Chapters in this book
- Frontmatter i
- CONTENTS vii
- FOREWORD ix
- INTRODUCTION 1
- 1. HARD WORK 10
- 2. THE ROCKEFELLER EFFECT 18
- 3. THE SHAPING OF A SCIENTIFIC MIND 25
- 4. THE ROCKEFELLER UNIVERSITY AND THE BROAD HORIZON 39
- 5. DIABETES 47
- 6. GLUCOSE, AGING, AND THE CROSS-LINKING OF BIOLOGY AND BUSINESS 56
- 7. THE CONCEPTUAL BREAKTHROUGH 71
- 8. CACHECTIN—TUMOR NECROSIS FACTOR 86
- 9. LEAVING THE ROCKEFELLER UNIVERSITY: The End of the Dream 101
- 10. PHILANTHROPY GOES AWRY 116
- 11. TRANSLATION IN TRANSITION 125
- 12. ANTI-TNF THERAPY Changing the Pharmaceutical Landscape 138
- 13. TAKING ON BIG PHARMA 144
- ACKNOWLEDGMENTS 163
- NOTES 165
- INDEX 191
- ABOUT THE AUTHOR 203
Chapters in this book
- Frontmatter i
- CONTENTS vii
- FOREWORD ix
- INTRODUCTION 1
- 1. HARD WORK 10
- 2. THE ROCKEFELLER EFFECT 18
- 3. THE SHAPING OF A SCIENTIFIC MIND 25
- 4. THE ROCKEFELLER UNIVERSITY AND THE BROAD HORIZON 39
- 5. DIABETES 47
- 6. GLUCOSE, AGING, AND THE CROSS-LINKING OF BIOLOGY AND BUSINESS 56
- 7. THE CONCEPTUAL BREAKTHROUGH 71
- 8. CACHECTIN—TUMOR NECROSIS FACTOR 86
- 9. LEAVING THE ROCKEFELLER UNIVERSITY: The End of the Dream 101
- 10. PHILANTHROPY GOES AWRY 116
- 11. TRANSLATION IN TRANSITION 125
- 12. ANTI-TNF THERAPY Changing the Pharmaceutical Landscape 138
- 13. TAKING ON BIG PHARMA 144
- ACKNOWLEDGMENTS 163
- NOTES 165
- INDEX 191
- ABOUT THE AUTHOR 203
